Key clinical point: Patients with high pancreatic cancer risk should be considered for screening.
Major finding: Two first-degree relatives with pancreatic cancer confers an 8%-12% lifetime risk.
Study details: Expert review commissioned by the American Gastroenterological Association Institute Clinical Practice Updates Committee.
Disclosures: Harry R. Aslanian, MD, AGAF, and coauthors did not provide any disclosures.
Source: Aslanian HR et al. Gastroenterology. 2020. doi: 10.1053/j.gastro.2020.03.088.
Aslanian HR et al. Gastroenterology. 2020. doi: 10.1053/j.gastro.2020.03.088.